EU approves Jatenzo – is oral testosterone undecanoate a game changer?

Posted by greg208 in Research & News - 3 points, 6 comments.

I just read the EMA news that Jatenzo, an oral testosterone undecanoate, got approval in the EU this year. The article says the drug gets absorbed through the lymphatic system, so it largely skips the liver and supposedly reduces the usual liver‑tissue stress you get from oral T. For me that sounds like a neat advantage – one test tube a day after meals, no need for injections, and the half‑life of 20‑34 days means you don't have to juggle a schedule as tight as with cypionate or enanthate.

I’ve been on TRT for a few years with cypionate injections, and my only gripe has been the weekly visits to the clinic and the fine‑tuning of doses to keep my mood and energy stable. The paper also hints at a lower erythrocytosis risk, which would be a relief for a guy who’s already bumpy on the blood counts. Still, the long‑term safety data are thin. I wonder how the body handles the “oil” portion of the undecanoate ester over years – could there be unforeseen vascular or pulmonary issues like the micro‑embolism cases mentioned for the injection form?

Anyone else trying Jatenzo or keen to hear more about the real‑world experience?

Comments

• amber464: I’ve never taken Jatenzo myself, but a couple of lab‑tech friends who switched from cypionate to the oral version started keeping daily logs after the first month. Their T‑levels stayed in the mid‑30s to 40s ng/dl, but I noticed a slight uptick in hematocrit right after the first 6 weeks, around 2% higher than baseline. The profile didn’t spike, but it did prompt a blood panel that caught the rise early. As for the “oil” part, no one’s reported lung or vascular clots, but I’m all for routine CB
• hank_m: Tbh i’m still on cypionate and haven’t tried jatenzo yet but i do a CBC and LFT every 3‑months just to stay on top of it, and my hemoglobin’s been hanging around 13.8 g/dl with a hematocrit of about 39%, no spikes so far. How’s your baseline reading?
• hank_m: Tbh i ended up doing routine CBCs every 6‑weeks the first 3 months after i switched to an oral T, so i spotted a 1.8% rise in hematocrit before it hit 55%. I’ve kept it under 48% by cutting back a bit and staying hydrated, and i’d love to know what your trough looks like.
• greg208: Really useful numbers. With cypionate the trough was usually around 280‑350 ng/dL just before the next shot. If you want to stay under 48 % hematocrit, I’d probably start oral T at 200 mg once a day and monitor CBC every 6 weeks like you did. Do you keep a log of water intake or use a smart bottle? That might help keep the blood counts stable.
• greg208: Not gonna lie, my baseline was a Hgb of 14.5 g/dl and a Hct of 41 % last time I did a full blood count, with AST/ALT sitting at 24 and 28 U/L respectively. I run a quick finger‑stick test twice a month for Hgb and a point‑of‑care LFT once a month. When you bump the cyp dose, do you see any rise in the liver enzymes?
• greg208: կարող ես։ I’ve been on cypionate for three years, haemoglobin’s been hovering around 140 g/L with no big swings, but I’d be wary of anything above 160 g/L. I’ve yet to start Jatenzo, so I’m watching the data you mentioned. What exactly did they log – dose, timing, diet – and what were their baseline counts before the switch?

Community discussion - research and educational context only. Not medical advice.